Shandong Lukang Pharmaceutical(600789) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?
Simply Wall StMar 26 18:08 ET
Shandong Lukang Pharmaceutical Raising Subsidiary's Capital for Business Expansion
MT NewswiresMar 24 05:20 ET
Lukang Pharmaceutical: Summary of Lukang Pharmaceutical\'s 2024 Annual Report
SZSIMar 21 12:00 ET · Announcements
Lukang Pharmaceutical: 2024 Annual Report of Lukang Pharmaceutical
SZSIMar 21 12:00 ET · Announcements
2024 Annual Report of Lukang Pharmaceutical
SZSIMar 21 12:00 ET · Announcements
Summary of the 2024 Annual Report of Lukang Pharmaceutical
SZSIMar 21 12:00 ET · Announcements

Comments

Moomoo AI

Feb 15, 2024 07:06

The company's low ROE and stagnant net income growth over the past five years are worrisome. Despite high profit retention, the low return rate may be hindering earnings growth. The market seems to overlook the company's positive fundamentals, focusing more on the negatives.

Is The Market Rewarding Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

1

Moomoo AI

Jan 19, 2024 07:36

The company's low P/E ratio is due to declining medium-term earnings. Investors see no significant potential for earnings improvement to justify a higher P/E ratio. Without profitability improvement, the P/E ratio could fall even lower.

Why Investors Shouldn't Be Surprised By Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Low P/E

600789 Shandong Lukang Pharmaceutical

Trade Overview

Capital Trend

News

Comments

Market Insights